Family Care Hospitals (BSE 516110)₹1.96−0.51%Healthcare Service Provider
In the Jun 2026 quarter (standalone), Family Care Hospitals reported sales of ₹0.04 Cr, up 300.0% from Jun 2025, and net profit of −₹0.41 Cr. For the year to Mar 2026, sales were ₹0.20 Cr and net profit −₹8.67 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.42 | 11.39 | 4.23 | 3.96 | 3.89 | 0.02 | 0.01 | 0.01 | 0.06 | 0.05 | 0.05 | 0.04 |
| Expenses | 10.41 | 9.90 | 3.28 | 3.73 | −27.10 | 1.77 | 1.05 | 0.39 | 4.44 | 0.74 | −2.00 | 0.21 |
| Operating Profit | 2.02 | 1.50 | 0.98 | 0.24 | 31.05 | −1.76 | −1.05 | −0.39 | −4.39 | −0.70 | 2.08 | −0.18 |
| OPM % | 16.1% | 13.1% | 22.9% | 5.8% | 798.2% | −5,833.4% | −5,200.0% | −1,900.0% | −6,257.2% | −1,150.0% | 3,450.0% | −340.0% |
| Other Income | 0.25 | 0.56 | 2.07 | 0.47 | −73.81 | 0.00 | 2.02 | 0.00 | 0.09 | 0.02 | −4.16 | 0.00 |
| Interest | 0.16 | 0.10 | 0.10 | 0.10 | 0.07 | 0.08 | 0.08 | 0.09 | 0.11 | 0.09 | 0.13 | 0.07 |
| Depreciation | 0.37 | 0.37 | 0.35 | 0.33 | 0.29 | 0.29 | 0.26 | 0.24 | 0.24 | 0.23 | 0.21 | 0.21 |
| Profit before tax | 1.77 | 1.62 | 2.63 | 0.31 | −43.45 | −2.11 | 0.68 | −0.70 | −4.62 | −0.97 | −2.43 | −0.43 |
| Tax % | 28.4% | 30.5% | −227.5% | 26.7% | −0.2% | 0.0% | −47.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | −74.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −4.29 | 0.00 |
| Net Profit | 1.25 | 1.11 | 8.56 | 0.22 | −43.23 | −2.09 | 0.98 | −0.69 | −4.60 | −0.95 | −2.41 | −0.41 |
| EPS (Rs) | 0.22 | 0.20 | 1.58 | 0.03 | −8.00 | −0.38 | 0.17 | −0.14 | −0.84 | −0.17 | −0.46 | −0.07 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.06 | 1.79 | 5.18 | 14.20 | 13.24 | 35.37 | 42.09 | 42.06 | 40.00 | 7.89 | 0.20 | 0.20 |
| Expenses | 0.87 | 1.53 | 3.83 | 12.72 | 10.99 | 27.19 | 33.38 | 33.56 | 33.13 | −21.30 | 3.59 | 3.39 |
| Operating Profit | 0.22 | 0.27 | 1.36 | 1.47 | 2.28 | 8.20 | 8.73 | 8.47 | 6.91 | 29.28 | −3.40 | −3.19 |
| OPM % | 19.6% | 14.5% | 26.0% | 10.3% | 17.1% | 23.1% | 20.7% | 20.1% | 17.2% | 370.0% | −1,614.3% | −1,595.0% |
| Other Income | 0.19 | 0.18 | 0.23 | 0.03 | −0.11 | −0.27 | 0.29 | 0.97 | 3.18 | −71.61 | −4.03 | −4.05 |
| Interest | 0.02 | 0.02 | 0.13 | 0.52 | 0.85 | 0.84 | 0.51 | 0.61 | 0.54 | 0.87 | 0.38 | 0.40 |
| Depreciation | 0.39 | 0.26 | 0.40 | 0.95 | 1.29 | 1.43 | 1.45 | 1.42 | 1.43 | 1.14 | 0.89 | 0.89 |
| Profit before tax | 0.03 | 0.20 | 1.09 | 0.06 | 0.04 | 5.67 | 7.08 | 7.44 | 8.15 | −44.59 | −8.70 | −8.45 |
| Tax % | 0.0% | 21.0% | 20.4% | 60.0% | 33.4% | 28.0% | 26.3% | 29.1% | −54.2% | −0.7% | 0.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −75.07 | −4.01 | −4.29 |
| Net Profit | 0.01 | 0.15 | 0.85 | 0.01 | 0.02 | 4.06 | 5.19 | 5.25 | 12.52 | −44.10 | −8.67 | −8.37 |
| EPS (Rs) | 0.00 | 0.03 | 0.11 | 0.00 | 0.00 | 0.57 | 0.70 | 0.96 | 2.31 | −8.16 | −1.62 | −1.54 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 6.2% | 5.1% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32.02 | 32.04 | 32.03 | 32.04 | 32.03 | 32.03 | 32.03 | 32.03 | 53.91 | 54.02 | 53.91 | 53.95 |
| Reserves | −28.10 | −28.10 | −27.96 | −27.09 | −27.10 | −27.05 | −22.98 | −17.78 | −8.17 | 4.35 | −40.44 | −44.37 |
| Borrowings | 0.57 | 0.57 | 0.11 | 0.29 | 5.61 | 9.55 | 5.52 | 4.27 | 4.33 | 3.66 | 3.40 | 5.18 |
| Other Liabilities | 0.03 | 0.07 | 1.29 | 4.63 | 3.21 | 2.57 | 5.78 | 21.28 | 24.52 | 7.98 | 29.26 | 28.32 |
| Total Liabilities | 4.52 | 4.58 | 5.47 | 9.87 | 13.75 | 17.10 | 20.35 | 39.80 | 74.59 | 70.01 | 46.13 | 43.08 |
| Fixed Assets | 1.73 | 1.83 | 2.43 | 7.22 | 8.57 | 9.49 | 7.98 | 6.80 | 6.90 | 5.93 | 3.99 | 2.89 |
| CWIP | 0.00 | 0.00 | 0.59 | 0.85 | 0.05 | 0.03 | 0.08 | 0.08 | 0.08 | 0.05 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 2.79 | 2.75 | 2.45 | 1.80 | 5.13 | 7.58 | 12.29 | 32.92 | 67.61 | 64.03 | 42.14 | 40.19 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.08 | 0.20 | 0.30 | 0.31 | 0.16 | 0.26 | 0.65 | 38.15 | 38.14 |
| Trade receivables | 0.00 | 0.00 | 0.00 | 0.00 | 2.50 | 4.10 | 9.02 | 21.47 | 29.01 | 34.01 | 2.03 | 1.02 |
| Cash & equivalents | 2.75 | 2.60 | 2.39 | 0.25 | 0.48 | 1.62 | 0.45 | 0.22 | 19.30 | 17.48 | 0.23 | 0.27 |
| Total Assets | 4.52 | 4.58 | 5.47 | 9.87 | 13.75 | 17.10 | 20.35 | 39.80 | 74.59 | 70.01 | 46.13 | 43.08 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.08 | 0.35 | 0.47 | 3.05 | −4.13 | −1.30 | 3.91 | 1.69 | −5.27 | −0.38 | −17.33 | −5.45 |
| Cash from investing activity | −1.76 | −0.49 | −1.46 | −5.44 | −1.52 | −2.31 | −0.27 | −0.24 | −1.55 | −0.42 | 0.66 | 0.00 |
| Cash from financing activity | 4.53 | 0.00 | 0.77 | 0.25 | 5.87 | 4.74 | −4.83 | −1.66 | 25.88 | −1.03 | −0.56 | 6.06 |
| Net cash flow | 2.67 | −0.13 | −0.20 | −2.13 | 0.22 | 1.13 | −1.16 | −0.22 | 19.01 | −1.82 | −17.14 | 0.62 |
| Capex | 1.76 | 0.47 | 1.44 | 5.44 | 1.50 | 2.84 | 0.77 | 0.33 | 2.04 | 0.44 | 0.26 | 0.00 |
| Free cash flow | −1.85 | −0.13 | −1.00 | −2.42 | −5.62 | −3.60 | 3.63 | 1.41 | −6.79 | −0.79 | −16.66 | −5.43 |
| CFO / OP % | 41.0% | 162.0% | 192.0% | 241.0% | −280.1% | −56.0% | 67.0% | 41.0% | −39.0% | −74.0% | −60.0% | 160.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 0 | 0 | 0 | 64 | 112 | 92 | 185 | 251 | 309 | 92 | 1,754 |
| Inventory days | — | — | — | — | — | 149 | 29 | 4 | 6 | 16 | — | 1,38,810 |
| Days payable | — | — | — | — | — | 978 | 213 | 383 | 388 | 114 | — | 86,287 |
| Cash conversion cycle | 0 | 0 | 0 | 0 | 66 | −714 | −88 | −192 | −128 | 215 | 94 | 54,280 |
| Working capital days | −2,920 | −160 | −272 | −312 | −146 | −16 | 55 | 100 | 149 | 255 | 402 | 9,855 |
| ROCE % | −4.0% | 0.7% | 4.6% | 25.5% | 7.1% | 8.1% | 46.6% | 45.8% | 23.4% | 15.5% | 79.3% | −25.6% |
For the Jun 2026 quarter, Family Care Hospitals reported sales of ₹0.04 Cr, up 300.0% year on year and net profit of −₹0.41 Cr. The operating margin was −340.0%.
Family Care Hospitals' sales for the year to Mar 2026 were ₹0.20 Cr; over the last twelve months they were ₹0.20 Cr.
Net profit for the year to Mar 2026 was −₹8.67 Cr, and −₹8.37 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−1.54.
Family Care Hospitals reported borrowings of ₹5.18 Cr at Mar 2026, against cash and equivalents of ₹0.27 Cr.
Cash from operations was −₹5.45 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹5.43 Cr.